Laser zaps brain tumor regrowth without delaying key therapy
NCT ID NCT07616986
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a minimally invasive laser treatment for glioblastoma that regrows shortly after initial surgery, before standard radiotherapy and chemotherapy begin. The goal is to see if the laser can safely treat the regrowth without delaying the planned follow-up treatments. Only 12 adults with glioblastoma will participate, and the main focus is on whether the treatment schedule can be maintained.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
Laser interstitial thermal therapy (LITT) - a minimally invasive procedure using heat from a laser to destroy tumor tissue
What this could lead to
If successful, this could offer a way to treat early glioblastoma regrowth without delaying standard radiotherapy and chemotherapy, potentially improving survival.
What could go wrong
This is a very small, early feasibility study with only 12 participants. The procedure carries risks like bleeding, infection, or brain swelling, and it may not improve outcomes.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GLIOBLASTOMA (GBM) are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Dep. of Neurosurgery, Bern University Hospital
RECRUITINGBern, 3010, Switzerland
Contact